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Evidence for Differential Glycosylation of
Trophoblast Cell Types*□
S

Qiushi Chen‡, Poh-Choo Pang‡, Marie E. Cohen§, Mark S. Longtine¶,
Danny J. Schust储, Stuart M. Haslam‡, Sandra M. Blois**¶¶, Anne Dell‡¶¶,
and Gary F. Clark储¶¶
Human placental villi are surfaced by the syncytiotrophoblast (STB), with a layer of cytotrophoblasts (CTB) positioned just beneath the STB. STB in normal term pregnancies is exposed to maternal immune cells in the placental
intervillous space. Extravillous cytotrophoblasts (EVT) invade the decidua and spiral arteries, where they act in
conjunction with natural killer (NK) cells to convert the
spiral arteries into flaccid conduits for maternal blood that
support a 3– 4 fold increase in the rate of maternal blood
flow into the placental intervillous space. The functional
roles of these distinct trophoblast subtypes during pregnancy suggested that they could be differentially glycosylated. Glycomic analysis of these trophoblasts has revealed the expression of elevated levels of biantennary
N-glycans in STB and CTB, with the majority of them
bearing a bisecting GlcNAc. N-glycans terminated with
polylactosamine extensions were also detected at low
levels. A subset of the N-glycans linked to these trophoblasts were sialylated, primarily with terminal NeuAc␣2–
3Gal sequences. EVT were decorated with the same Nglycans as STB and CTB, except in different proportions.
The level of bisecting type N-glycans was reduced, but the
level of N-glycans decorated with polylactosamine sequences were substantially elevated compared with the
other types of trophoblasts. The level of triantennary and
tetraantennary N-glycans was also elevated in EVT. The
sialylated N-glycans derived from EVT were completely
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susceptible to an ␣2–3 specific neuraminidase (sialidase S).
The possibility exists that the N-glycans associated with
these different trophoblast subpopulations could act as
functional groups. These potential relationships will be
considered. Molecular & Cellular Proteomics 15: 10.1074/
mcp.M115.055798, 1857–1866, 2016.

Human development in utero requires the formation of a
functional placenta that mediates the transport of nutrients,
the exchange of gases, and the production of hormones that
are required to maintain fetal viability. The placenta also
serves as the immune interface between the mother and her
histoincompatible fetus. Human trophoblasts are specialized
placental cells that come into direct physical contact with
maternal immune cells at both the villous surface and within
the maternal decidua and myometrium. The syncytiotrophoblast (STB)1 layer is localized to the villous surface, with
subsyncytial cytotrophoblasts (CTB) lying just beneath the
STB. Regions of the syncytium can become damaged, which
occurs at an increased frequency in many complicated pregnancies, and this damage can be repaired by division and
fusion of cytotrophoblasts. It is likely that CTB in these damaged regions are at least transiently in direct contact with
circulating maternal immune cells (1, 2).
Extravillous cytotrophoblasts (EVT) derived from placental
stem cells penetrate through the tips of the anchoring villi and
differentiate into invasive trophoblasts that migrate into the
decidua, myometrium and spiral arteries (3). Trophoblasts that
enter the spiral arteries differentiate into endovascular cytotrophoblasts. These cytotrophoblasts act in concert with
maternal NK cells to remodel these arteries into flaccid conduits that support a three- to fourfold increase in the rate of
maternal blood flow into the placental intervillous space at a
reduced pressure compared with the maternal circulation
(4 – 6).
1

The abbreviations used are: STB, syncytiotrophoblast; BBSCT,
biantennary bisected type; CFG, Consortium for Functional Glycomics; CTB, cytotrophoblasts; dNK, decidual natural killer; EVT, extravillous cytotrophoblasts; HLA, human leukocyte antigen; LacNAc,
N-acetyllactosamine; NK, natural killer; PAEP, progestagen-associated endometrial protein; PMAA, partially methylated alditol acetate.
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Interactions between villous trophoblasts and maternal immune cells would normally be expected to trigger major histocompatibility responses because of the expression of paternal human leukocyte antigens (HLA). However, STB and
CTB do not express the HLA class I molecules that are necessary to evoke such responses (7, 8). This absence of HLA
molecules on STB and CTB could make these trophoblasts
potential targets for lysis by NK cells (9). However, STB and
CTB are highly resistant to lysis by peripheral blood NK cells
in vitro (10, 11).
Unlike CTB and STB, EVT express on their cell surface a
classical paternal HLA class Ia molecule designated HLA-C
(7, 8). This presentation means that EVT are semiallogeneic
during natural pregnancies and are therefore potentially subject to powerful histocompatibility-based immune responses.
However, the activation of such responses in a manner that
harms the fetus and placenta does not typically occur during
normal pregnancies. How EVT evade immune recognition in
the gravid human uterus remains a major enigma. In contrast
to STB or CTB, EVT are also susceptible to lysis by purified
decidual NK (dNK) cells (12–14). Because EVT are the precursors of endovascular trophoblasts that remodel the spiral
arteries (15), increased lysis of EVT by activated dNK cells
could decrease the number of endovascular trophoblasts,
thereby contributing to deficient spiral artery remodeling and
inadequate circulation in the intervillous space.
Glycomic analyses of glycoproteins, whole cells, tissues,
and extracellular matrices have been useful for defining potential carbohydrate functional groups and their diverse roles
in many cellular processes (16 –21). Glycomic analysis of STB,
CTB, and EVT was performed in this study to determine if the
N-glycans associated with these cells have potential functional roles.
EXPERIMENTAL PROCEDURES

Isolation of CTB and STB—The protocol for obtaining placentas
used for this portion of this study was approved by the Institutional
Review Board of Washington University School of Medicine. Term,
singleton placentas from uncomplicated pregnancies were obtained,
and CTB were isolated as described previously (22, 27). All reagents
were obtained from Sigma-Aldrich (St. Louis, MO) except for DNase,
which was from Roche Diagnostics (Indianapolis, IN). In brief, villous
tissue was isolated and digested with dispase, trypsin, and DNase
and CTB were isolated on a continuous gradient of Percoll. Over 85%
of the cells stained positive for cytokeratin 7, a TB specific marker.
CTB were obtained after 24 h of culture in DMEM/10% FBS in 5%
CO2/air. To obtain STB, culture was continued for an additional 48 h
with daily changes of medium. During this time, spontaneous differentiation and fusion occurs, with over 70% of the nuclei being present
in multinucleated syncytia after 72 h of culture (22). We observed an
⬃50-fold increase of hCG expression from 24 to 72 h of culture,
confirming efficient differentiation.
Isolation of EVT—All human tissue collection necessary for this
study was approved by the local ethics committee of the Geneva
University Hospital. All patients provided their informed written consent prior to their inclusion in the study. Placental tissue was obtained
from patients undergoing an elective termination of pregnancy during
the first trimester (8 –12 weeks of gestation). The procedure for the
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isolation of EVT was performed as previously described (23). Placental tissue specimens were isolated and washed several times in sterile
Hanks balanced salt solution. The tissue samples were subjected to
enzymatic digestion five times for 20 min at 37 °C (0.25% trypsin,
0.25 mg/ml Dnase I; Roche, Diagnostics GmbH). After this incubation,
fetal bovine serum (FBS) was added to neutralize the trypsin mixture.
The cells were suspended in Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen, Switzerland). This cell suspension was filtered
through a 50-m mesh and the resulting supernatant was applied
onto tubes containing a Percoll gradient (70 –5% Percoll diluted with
HBSS). The samples were centrifuged for 25 min at 1200 ⫻ g. The
30 – 45% Percoll layer was collected, and the trophoblast cells were
harvested, washed, and resuspended in DMEM containing 10% fetal
bovine serum.
The cells were transferred to Petri dishes and incubated for 15 min
at 37 °C. Trophoblasts in the culture supernatants were collected by
centrifugation and resuspended in culture medium. They were transferred to six-well plates (4 ⫻ 106 cells/well) and in 96-well plates (1 ⫻
105 cells/well). After 48 h of culture, 95% of the cells were: (1) negative
for vimentin; and (2) positive for cytokeratin 7 and HLA-G.
Processing of Trophoblasts to Acquire N- and O-glycans—All cell
samples were subjected to a standard protocol (24). Briefly, cells
were suspended in lysis buffer (25 mM Tris, 150 mM NaCl, 5 mM EDTA
and 1% CHAPS (v/v), pH 7.4) before homogenization and sonication
were performed. The homogenates were subsequently dialyzed
against a 50 mM ammonia bicarbonate buffer, pH 7.5, after which the
samples were lyophilized. Cell/tissue extracts were reduced and carboxymethylated and then treated with trypsin. The treated samples
were purified using a C18 cartridge (Oasis HLB Plus, Waters, Milford,
MA) prior to the release of N-glycans by peptide N-glycosidase F
(recombinant from Escherichia coli, Roche Applied Science, Penzberg, Germany) digestion. Released N-glycans were permethylated
and then purified using a Sep-Pak C18 cartridge (Waters) prior to MS
analysis.
Purified, underivatized N-glycans were incubated with sialidase S
(recombinant from Streptococcus pneumonia, Prozyme Glyko, Hayward, CA) or ␤1,4-galactosyltransferase (from bovine milk, Merck,
Kenilworth, NJ) separately. Sialidase S digestion was carried out
using sialidase S in 50 mM sodium acetate, pH 5.5. The ␤1,4-galactosyltransferase reaction was performed using ␤1,4-galactosyltransferase in 50 mM 3-(N-morpholino)-propanesulfonic acid (MOPS) containing 45 M UDP-Gal, pH 7.4. The resulting enzyme-treated
samples were lyophilized and permethylated prior to MS analysis.
Mass Spectrometric Analysis—MS data were obtained by using a
Voyager-DETM STR MALDI-TOF (Applied Biosystems, Foster City,
CA) mass spectrometer. Purified permethylated glycans were dissolved in 10 l methanol and 1 l of the sample was mixed with 1 l
of matrix, 20 mg/ml 2,5-dihydroxybenzoic acid (DHB) in 70% (v/v)
aqueous methanol and loaded on to a metal target plate. The instrument was run in the reflectron positive ion mode. The accelerating
voltage was 20 kV. MS/MS data were acquired using a 4800 MALDITOF/TOF mass spectrometer (AB SCIEX, Framingham, MA). In the
MS/MS experiment, the dissolved sample was dried and then redissolved in 10 l methanol. 1 l of the sample was mixed with 1 l
of matrix, 10 mg/ml diaminobenzophenone (DABP) in 70% (v/v) aqueous acetonitrile and loaded on to a metal target plate. The instrument
was run in the reflectron positive ion mode. The collision energy was
set to 1 kV with argon as the collision gas. The 4700 calibration
standard (mass standards kit for the 4700 proteomics analyzer, Applied Biosystems) was used as the external calibrant for the MS and
MS/MS modes.
GC/MS Linkage Analysis—GC-MS linkage analysis of partially
methylated alditol acetates (PMAAs) was carried out using a PerkinElmer Life Sciences Clarus 500 instrument (Framingham, MA) fitted with
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RTX-5MS column (30 m ⫻ 0.32 mm internal diameter, Restek Corp.,
Bellefonte, PA). The PMAAs were prepared from permethylated Nglycans as described previously (25). The permethylated glycans
were hydrolyzed with 2 M trifluoroacetic acid at 121 °C for 2 h, and
then reduced with 10 mg/ml sodium borodeuteride in 2 M aqueous
ammonium hydroxide at room temperature for 2 h, and acetylated
with acetic anhydride at 100 °C for 1 h. The sample was dissolved in
hexanes and injected onto the column after the oven temperature
reached 60 °C. The column was maintained at this temperature for 1
min and then heated to 300 °C at a rate of 8 °C/min. Running a blank
was required before every sample analysis.
Experimental Design—
CTB N-glycans—(1) All N-glycans were presumed to have a Man␣1–
6(Man␣1–3)Man␤1– 4GlcNAc␤1– 4GlcNAc core structure based on
knowledge of the N-glycan biosynthetic pathway and PNGase F
specificity. (2) The composition (numbers of Hex, Fuc, etc.) of the
glycans derived from MALDI-TOF MS in positive ion mode were
manually interpreted. (3) MALDI-TOF/TOF MS/MS analyses were carried out on the following ions: m/z 2592, 2635, 2837, 2850, 3141,
3212, 3300, and 3416. All MS/MS spectra were annotated manually
with the assistance of a glycobioinformatics tool, GlycoWorkBench
(version 1.0.3353). (4) GC-MS linkage analysis was performed on
partially methylated alditol acetates (PMAAs). (5) Sialidase S digestion
was followed by manual assignment of the composition (numbers of
Hex, Fuc, etc.) of the glycans derived from MALDI-TOF MS in positive
ion mode. (6) Sialidase S digestion was followed by MALDI-TOF/TOF
MS/MS analyses of the following ions: m/z 3143 and 4939. All MS/MS
spectra were annotated manually with the assistance of a glycobioinformatics tool, GlycoWorkBench (version 1.0.3353). (7) The ␤1,4galactosyltransferase reaction was followed by manual assignment of
the composition (numbers of Hex, Fuc, etc.) of the glycans derived
from MALDI-TOF MS in positive ion mode.
STB N-glycans—(1) All N-glycans were presumed to have a
Man␣1– 6(Man␣1–3)Man␤1– 4GlcNAc␤1– 4GlcNAc core structure
based on knowledge of the N-glycan biosynthetic pathway and
PNGase F specificity. (2) The composition (numbers of Hex, Fuc, etc.) of
the glycans derived from MALDI-TOF MS in positive ion mode were
manually interpreted. (3) MALDI-TOF/TOF MS/MS analyses were carried out on the following ions: m/z 2592, 2635, 2837, 2850, 3141, 3212,
3300, and 3416. All MS/MS spectra were annotated manually with the
assistance of a glycobioinformatics tool, GlycoWorkBench (version
1.0.3353). (4) GC-MS linkage analysis was performed using partially
methylated alditol acetates (PMAAs). (5) Sialidase S digestion was followed by manual assignment of the composition (numbers of Hex, Fuc,
etc.) of the glycans derived from MALDI-TOF MS in positive ion mode.
(6) Sialidase S digestion was followed by MALDI-TOF/TOF MS/MS
analyses of following ions: m/z 3143 and 4939. All MS/MS spectra were
annotated manually with the assistance of a glycobioinformatics tool,
GlycoWorkBench (version 1.0.3353). The ␤1,4-galactosyltransferase reaction was followed by manual assignment of the composition (numbers of Hex, Fuc, etc.) of the glycans derived from MALDI-TOF MS in
positive ion mode.
EVT N-glycans—(1) All N-glycans were presumed to have a
Man␣1– 6(Man␣1–3)Man␤1– 4GlcNAc␤1– 4GlcNAc core structure
based on knowledge of the N-glycan biosynthetic pathway and
PNGase F specificity. (2) The composition (numbers of Hex, Fuc, etc.)
of the glycans derived from MALDI-TOF MS in positive ion mode were
manually interpreted. (3) MALDI-TOF/TOF MS/MS analyses were carried out on the following ions: m/z 2519, 2850, 3141, 3212, 3415,
3964, and 4041. All MS/MS spectra were annotated manually with the
assistance of a glycobioinformatics tool, GlycoWorkBench (version
1.0.3353). (4) Sialidase S digestion was followed by manual assignment of the composition (numbers of Hex, Fuc, etc.) of the glycans
derived from MALDI-TOF MS in positive ion mode. (5) Sialidase S
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digestion was followed by MALDI-TOF/TOF MS/MS analyses of following ions: m/z 2489, 2519, 2693, 2968, 3142, 3387, 4040, and
4489. All MS/MS spectra were annotated manually with the assistance of a glycobioinformatics tool, GlycoWorkBench (version
1.0.3353) (26).
The symbolic nomenclature used in the all the spectra annotations
(CTB, STB and EVT) is the same as the one used by the Consortium
for Functional Glycomics (CFG) (http://www.functionalglycomics.
org/) and the Essentials for Glycobiology on-line textbook (http://www.
ncbi.nlm.nih.gov/books/NBK1931/figure/ch1.f5/?report⫽objectonl).
RESULTS

Analysis of N-glycans Associated with CTB—A modification
of the Kliman procedure was employed to isolate samples of
CTB from eight term placentas (22, 27). Each sample was
subjected to glycomic profiling exactly as described in a
previous study (16). High quality MALDI data were obtained
for the N-glycans of all the CTB samples. There were no
apparent differences in the spectra between eight individuals.
A representative MALDI spectrum of N-glycans derived from
CTB from one patient is shown in Fig. 1. The theoretical and
observed m/z values of the glycans and the manual interpretation of the composition of these glycans are shown in supplemental Table S1. Signals for high mannose type N-glycans
(Man5–9GlcNAc2) were abundant at m/z 1579.8, 1783.9,
1988.0, 2192.1, and 2396.1. In addition numerous signals for
complex-type biantennary, triantennary and tetraantennary
N-glycans were observed, and their structures are shown in
the cartoon annotations in Fig. 1. To decrease the complexity
of all the MALDI spectrum figures, the cartoon annotations for
minor signals less than m/z 3250 are shown in supplemental
Table S2. Nearly all the complex-type glycans carry core ␣1– 6
linked fucose, consistent with their localization to the plasma
membrane, and sialic acid is the major capping sugar on their
N-acetyllactosamine antennae. The most abundant complextype structures give signals at m/z 2431.1 (mono-sialylated
biantennary), 2489.2 (non-sialylated, core fucosylated biantennary), 2850.3 (mono-sialylated, core fucosylated biantennary), 2966.3 (disialylated, core fucosylated biantennary), and
3211.4 (disialylated, core fucosylated biantennary). Interestingly three of these glycans have masses consistent with
biantennary bisected type (BBSCT) structures (m/z 2489.2,
2850.3, and 3211.4). Minor signals for N-glycans bearing
Lewisx (m/z 2592.2, 2837.3, 3024.3) and sialyl-Lewisx type
antenna (m/z 3140.3) were also detected. Evidence for Nglycans bearing polylactosamine type sequences was indicated by the signal at m/z 3299.5.
Additional experiments were performed to firmly establish
the glycan assignments shown in Fig. 1. First, to confirm
assignments of BBSCT glycans, the N-glycan mixture was
incubated with a ␤-galactosyltransferase in the presence of
UDP-Gal. This enzymatic modification adds galactose to all
antennae bearing terminal GlcNAc except for the bisecting
GlcNAc which is sterically inaccessible to the enzyme. After
this treatment, there was no detectable addition of galactose
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FIG. 1. Annotated MALDI-TOF MS spectra of permethylated N-glycans from CTB. The top panel shows the glycans in the mass range
from 1499 to 3250 and the bottom panel shows the glycans in the mass range from 3249 to 4700. In the top panel, minor peaks are only labeled
with their m/z values; their putative structures can be found in supplemental Table S2. Compared with the top panel, the bottom panel has been
magnified ⬃53 times. Because of the fact that the peak signal in the mass range from 3900 to 4700 in the bottom panel is very weak, this part
has been further magnified 5 times (upper trace). Profiles were obtained from the 50% acetonitrile fraction from a C18 Sep-Pak column. All ions
are [M⫹Na]⫹. Putative structures are based on the molecular weight, N-glycan biosynthetic pathway, MS/MS data and enzymatic digestion
results. Glycans at m/z 2966, 3777, and 4587 are clearly annotated, which is because of the fact that their structures are unequivocal because
each antenna is capped with a sialic acid and thus they are homogeneous bi-, tri-, and tetraantennary glycans. However, the glycan structure
is not always as unequivocal as the glycan at m/z 2966 as biosynthetically non-fully sialylated glycan molecular ion species could be made up
of mixtures of structural isoforms. Annotations are simplified to biantennary structures, with additional LacNAc units and capping sugars listed
outside the bracket, for mixtures of isobaric multiantennary glycans, some of which have antennae containing extended LacNAc repeats.

to putative BBSCT glycans (supplemental Fig. S1). In contrast, the truncated antennae of immature glycans (for example m/z 1835.9) were extended by galactose, confirming
that the ␤-galactosyltransferase was reacting successfully.
In addition, GC-MS linkage analysis of the glycan mixture
(supplemental Table S3) provided further evidence for the
presence of bisecting GlcNAc. The presence of Lewisx and
sialyl-Lewisx type antenna on these N-glycans was confirmed
by MS/MS analysis (supplemental Figs. S2, S3, S4). The
glycan mixture was also treated with sialidase S, a bacterial
neuraminidase that specifically hydrolyzes ␣2–3 linked sialic
acid. MS analysis of the products indicated that the majority
of the sialic acid was eliminated by this digestion. Substantial
amounts of sialic acid were released, but signals for sialylated
N-glycans remained at m/z 2431.2, 2676.3, 2880.3, and
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3241.4, indicating that they were likely terminated with ␣2– 6
linked sialic acid.
The N-glycans associated with CTB were treated with a
neuraminidase (sialidase S) that specifically removes terminal
␣2–3 linked sialic acid. This enzymatic step removed nearly all
of the sialic acid from these glycans, confirming that only a
minor amount of sialic acid was ␣2– 6 linked on glycoproteins
associated with this cell type (Fig. 2). The major N-glycans
that were detected after digestion were high mannose type
N-glycans and the BBSCT N-glycan. This desialylation step
also revealed minor amounts of N-glycans bearing polylactosamine sequences at m/z 3591.6, 3765.6, 3836.6, 4040.6,
4214.8, 4489.6, and 4938.6 (Fig. 2). MS/MS analysis of the
peak at m/z 4938.6 (4939) showed that the maximum number
of the LacNAc unit observed is five (supplemental Fig. S5).
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FIG. 2. Annotated MALDI-TOF MS spectra of permethylated sialidase S treated N-glycans from CTB (upper panel), STB (middle
panel) and EVT (lower panel). Profiles were obtained from the 50% acetonitrile fraction from a C18 Sep-Pak column. All ions are [M⫹Na]⫹.
Putative structures are based on the molecular weight, N-glycan biosynthetic pathway, MS/MS data and enzymatic digestion results.
Annotations are simplified to biantennary structures, with additional LacNAc units and capping sugars listed outside the bracket, for mixtures
of isobaric multiantennary glycans, some of which have antennae containing extended LacNAc repeats. Minor peaks are only labeled with their
m/z values; their putative structures can be found in supplemental Table S2.
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FIG. 3. Annotated MALDI-TOF MS spectra of permethylated N-glycans from STB86. The top panel shows the glycans in the mass range
from 1499 to 3250 and the bottom panel shows the glycans in the mass range from 3249 to 4700. In the top panel, minor peaks are only labeled
with their m/z values; their putative structures can be found in supplemental Table S2. Compared with the top panel, the bottom panel has been
magnified ⬃37 times. Because of the fact that the peak signal in the mass range from 3900 to 4700 in the bottom panel is weaker, this part
has been further magnified five times (upper trace). Profiles were obtained from the 50% acetonitrile fraction from a C18 Sep-Pak column. All
ions are [M⫹Na]⫹. Putative structures are based on the molecular weight, N-glycan biosynthetic pathway, MS/MS data and enzymatic
digestion results. Glycans at m/z 2966, 3777, and 4587 are clearly annotated, which is because of the fact that their structures are unequivocal
because each antenna is capped with a sialic acid and thus they are homogeneous bi-, tri-, and tetraantennary glycans. However, the glycan
structure is not always as unequivocal as the glycan at m/z 2966 as biosynthetically non-fully sialylated glycan molecular ion species could be
made up of mixtures of structural isoforms. Annotations are simplified to biantennary structures, with additional LacNAc units and capping
sugars listed outside the bracket, for mixtures of isobaric multiantennary glycans, some of which have antennae containing extended LacNAc
repeats.

Glycomic Analysis of Human STB—These trophoblasts
were obtained after in vitro differentiation of primary CTB as
described previously (22, 27). They were subjected to the
same procedure that was employed to analyze the CTB Nglycome (16). The theoretical and observed m/z values of the
glycans and the manual interpretations of the composition of
these glycans are shown in supplemental Table S4. There
were no apparent differences in the spectra between individuals. A representative MALDI spectrum is shown in Fig. 3.
There were essentially no differences in glycan expression
between STB and CTB. This same overlap was also observed
after sialidase S digestion of N-glycans derived from STB (Fig.
2). The major signals were for the high mannose type Nglycans (Man5–9GlcNAc2) and the BBSCT N-glycan (m/z
2489.1).
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Glycomic Analysis of Human EVT—This subpopulation of
trophoblasts was subjected to glycomic analysis to determine
if there were any differences between them and other types of
trophoblasts. The theoretical and observed m/z values of the
glycans and the manual interpretations of the composition of
these glycans are shown in supplemental Table S5. Although
the N-glycans linked to EVT were very similar to those associated with CTB and STB, there were major differences in
levels of expression (Fig. 4). The larger complex-type N-glycans were far more prevalent in EVT, which can be most
readily observed via the comparison of glycans after sialidase
S digestion (Fig. 2). The most abundant peak, after the removal of ␣2–3 linked sialic acid, was m/z 3141.7, which corresponds to a complex type N-glycan with four LacNAc units
in its antennae. This peak was accompanied by a prominent
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FIG. 4. Annotated MALDI-TOF MS spectra of permethylated N-glycans from EVT. The top panel shows the glycans in the mass range
from 1499 to 3250 and the bottom panel shows the glycans in the mass range from 3249 to 4700. Minor peaks are only labeled with their m/z
values; their putative structures can be found in supplemental Table S2. Compared with the top panel, the bottom panel has been magnified
⬃12 times. Profiles were obtained from the 50% acetonitrile fraction from a C18 Sep-Pak column. All ions are [M⫹Na]⫹. Putative structures
are based on the molecular weight, N-glycan biosynthetic pathway, MS/MS data and enzymatic digestion results. Glycans at m/z 2966, 3777,
and 4587 are clearly annotated, which is because of the fact that their structures are unequivocal because each antenna is capped with a sialic
acid and thus they are homogeneous bi-, tri-, and tetraantennary glycans. However, the glycan structure is not always as unequivocal as the
glycan at m/z 2966 as biosynthetically non-fully sialylated glycan molecular ion species could be made up of mixtures of structural isoforms.
Annotations are simplified to biantennary structures, with additional LacNAc units and capping sugars listed outside the bracket, for mixtures
of isobaric multiantennary glycans, some of which have antennae containing extended LacNAc repeats.

series of N-glycans with extended polylactosamine antennae
containing additional LacNAc moieties (m/z 3590.6, 4039.6,
4488.4, and 4937.3). These glycans were far more abundant
in EVT than in either CTB or STB. As a consequence, the
relative abundance of the BBSCT N-glycan approximately m/z
2489 became less prominent in the overall spectrum of EVT
compared with the other complex N-glycans. Another important difference was the absence of any detectable sialylated
glycans after digestion with sialidase S. This result confirmed
that all of the sialic acid associated with EVT is attached via
␣2–3 linkages.
DISCUSSION

The N-glycans associated with different types of human
trophoblasts were analyzed in this study. A specific caveat to
this analysis is that the STB were differentiated from CTB in
vitro (22, 27). However, the microvillous membrane of human
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STB derived from the placenta stain intensely with lectins that
bind to: (1) high mannose type N-glycans (Concanavalin A); (2)
biantennary bisecting type N-glycans (erythroagglutinating
phytohemagglutinin); (3) N-glycans bearing a core ␣1– 6
linked fucose (Pisum sativum agglutinin); and (4) terminal ␣2–3
linked sialic acid (Maackia amurensis agglutinin) (28). By contrast, these microvillous membranes stain very poorly with a
lectin that specifically binds to ␣2– 6 linked sialic acid (Sambucus nigra agglutinin) (28). These lectin binding results are
consistent with the glycomic analysis of STB presented in this
report.
The human placenta nourishes the fetus during its development. This organ also negotiates the peaceful co-existence
of the mother and her histoincompatible fetus during pregnancy. Specific adaptations have been made that enable
85–90% of women to fully accommodate their fetus until
development in utero is complete. Trophoblasts are placental
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FIG. 5. Differential glycosylation pattern expression on human trophoblast. This figure summarizes the types
of glycans that are characteristic of the
cytotrophoblast (CTB), syncytiotrophoblast (STB), and extravillous cytotrophoblast (EVT). All three cell types express
abundant high mannose glycans in addition to complex glycans. BBSCT Nglycans are found in all cell types, but
are more abundant in CTB and STB than
in EVT. EVT cells displayed higher levels
of multiantennary and polylactosamine
type N-glycans than CTB and STB. Abbreviations: fetal vessel (fv); maternal
blood; uterine artery (ua). f GlcNAc F
Man F Gal Œ Fuc ⽧ NeuAc.

cells that encounter maternal immune cells at two distinct
interfaces. STB and CTB interact with maternal immune cells
at the villous interface. EVT and their derivatives come into
direct physical contact with maternal immune cells during
their invasion of the decidua, myometrium and spiral arteries.
The current study was undertaken to determine if functional
glycosylation of trophoblasts could contribute to accommodation of the histoincompatible human fetus.
Glycosylation of Villous Trophoblasts—Our glycomic analyses of CTB and STB reveal that these cells express both high
mannose and complex-type glycans. The majority of the latter
are core fucosylated, biantennary structures with LacNAc or
oligo-LacNAc antennae that are partially capped with ␣2–3
linked (major) or ␣2– 6 linked (minor) sialic acid. A tiny portion
of the glycome carries fucosylated antennae in Lewisx/y and
sialyl-Lewisx-type sequences. Significantly, many of the biantennary glycans have a bisecting GlcNAc. These N-glycans
have previously been implicated in the suppression of NK
cell cytotoxicity in highly specialized assay systems (29, 30).
STB and CTB are highly resistant to NK cell-mediated cytotoxicity in vitro (10, 11). Whether or not this elevated
expression of biantennary bisecting type N-glycans on STB
and CTB plays a role in protecting these HLA class I negative cell types from NK cell mediated cytotoxicity is a topic
for further investigation.
Expression of Glycans on EVT—Notably, the profile of Nglycans in EVT was different from those observed in villous
trophoblasts, with EVT expressing relatively lower levels of
biantennary bisecting type N-glycans and much higher levels
of triantennary and tetraantennary N-glycans. N-glycans decorated with polylactosamine sequences were also considerably elevated in EVT compared with either CTB or STB. Unlike
these villous trophoblasts, the sialylated N-glycans associated with EVT were also exclusively capped with ␣2–3 linked
NeuAc. Our finding of the expression of polylactosamine-
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decorated N-glycans in EVT support previous findings by
Fisher and coworkers. These investigators demonstrated that
HLA-G produced by EVT and secreted into amniotic fluid
migrates as a polydisperse band between 35–50 kDa that is
collapsed into a single 35–36 kDa band after digestion with
endo-␤-galactosidase, an enzyme that specifically depolymerizes polylactosamine sequences (31, 32). Together,
these findings suggest that a substantial proportion of native
HLA-G molecules in EVT are decorated with polylactosamine
sequences.
The expression of bisecting type N-glycans, though lower
than in STB or CTB, could nonetheless provide EVT with
some measure of protection from dNK cell responses. However, the exact level of protection remains a matter of conjecture with the available data. Results from one study suggest that dNK cells are incapable of forming mature activating
synapses with EVT and thus are not cytotoxic (33). Other
groups have reported that EVT are susceptible to lysis by dNK
cells (12–14). Fisher and coworkers have provided evidence
that decidual macrophages induce tolerance to EVT via their
secretion of transforming growth factor-␤1 (12). These observations are complicated by the presence of glycodelin-A and
CA125, two soluble factors that are produced in abundance in
the endometrium and decidua from the initiation of implantation up until the 20th week of gestation. Glycodelin-A and
CA125 also suppress NK cell cytotoxicity in vitro (34 –38). NK
cell cytotoxicity is also directly suppressed by galectin-3 that
is also present at elevated levels in the uterus during pregnancy (39, 40). These findings suggest that there are likely
redundant pathways for the induction of NK cell tolerance in
the endometrium and decidua during the first two trimesters
of human pregnancy.
Expression of Galectins (LGALS) and Galectin Ligands in
the Pregnant Uterus—Galectins are a family of ␤-galactoside
binding proteins that express one or two conserved carbohy-
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drate recognition domains (40 – 42). Elevated expression of
GALS-1, -3, -8, -9, -13, -14, and -16 has been documented in
the placenta and the endometrium/decidua during human
pregnancy (40). Galectins act as both extracellular and intracellular modulators of diverse biological activities including
trophoblast migration and invasion, syncytium formation, and
immune modulation (41– 45).
Several groups have tested the carbohydrate binding specificities of galectins via a variety of different methods (46 – 49).
Considerable data have been obtained by analyzing the binding of galectins to different versions of the glycan array available on the public Consortium for Functional Glycomics (CFG)
web site (http://www.functionalglycomics.org). Galectins are
characterized by a near universal affinity for lacNAc (Gal␤1–
4GlcNAc). Many can accommodate substitution of the terminal ␤-linked Gal at the 3 but not the 6 position (46 – 49). This
specificity confirms that galectins can bind to terminal
NeuAc␣2–3Gal␤1– 4GlcNAc sequences, but not to those
capped with NeuAc␣2– 6Gal␤1– 4GlcNAc sequences (46).
Nearly all of the sialic acid associated with STB and CTB was
determined to be ␣2–3 linked in the current analyses. Only
␣2–3 linked sialic acid was detectable in the N-glycans derived from EVT. Galectins also display higher affinity for triantennary and tetraantennary N-glycans terminated with LacNAc sequences than for biantennary N-glycans of the same
type (46 – 49). Galectin-3, -8, and -9 present in the uterus
preferentially exhibit higher affinity for polylactosamine sequences (46). Glycomic analyses performed in this study indicate that EVT express a higher level of polylactosamine
sequences and tri- and tetraantennary N-glycans. Galectin-1
binds to the biantennary bisecting type N-glycan based on
glycan array data available at the CFG website. This specificity is consistent with the binding of galectin-1 to the surface of
CTB that was reported in a previous study (50). Analysis of
galectin binding to STB, CTB and EVT could be useful in the
future for defining the immune modulatory effects of these
carbohydrate binding proteins in the female urogenital tract.
In summary, in this study we have performed glycomic
analysis of CTB, STB and EVT. We observed complex N-glycosylation on all of these cell types. The results of this study
suggest the possibility that maternal-fetal tolerance could be
influenced by the differential glycosylation of human trophoblasts populations. Whether aberrant glycosylation could
contribute to inappropriate maternal-fetal immune response
and poor pregnancy outcomes is certainly an issue for further
investigation. Testing of these hypotheses will involve the analysis of glycosylation in trophoblasts in normal and complicated pregnancies, characterization of glycosylation changes
in trophoblasts during development, and immunological analysis of any observed differences to determine their effects on
maternal-fetal tolerance.
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